XML 18 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
RESTRUCTURING CHARGES
9 Months Ended
Sep. 30, 2013
Restructuring Charges [Abstract]  
RESTRUCTURING CHARGES
RESTRUCTURING CHARGES AND OTHER, NET
September 2012 Program
In September 2012, the Company announced a worldwide restructuring (the “September 2012 Program”), which primarily involved the Company exiting its owned manufacturing facility in France and its leased manufacturing facility in Maryland; rightsizing its organizations in France and Italy; and realigning its operations in Latin America, including consolidating Latin America and Canada into a single operating region, which became effective in the fourth quarter of 2012.
A summary of the restructuring and related charges incurred through September 30, 2013 and expected to be incurred for the September 2012 Program, are as follows:
 
Restructuring Charges and Other, Net
 
 
 
 
 
 
 
 
 
Employee Severance and Other Personnel Benefits
 
Other
 
Total Restructuring Charges and Other, Net
 
Returns (a)
 

Inventory Write-offs (b)
 

Other Charges (c)
 
Total Restructuring and Related Charges
Charges incurred through December 31, 2012(d)
$
18.4

 
$
2.3

 
$
20.7

 
$
1.6

 
$
1.2

 
$
0.6

 
$
24.1

Charges (benefits) incurred for the nine months ended September 30, 2013 (e)
2.6

 
(0.8
)
 
1.8

 

 
0.2

 
0.2

 
2.2

Cumulative charges incurred through September 30, 2013
$
21.0

 
$
1.5

 
$
22.5

 
$
1.6

 
$
1.4

 
$
0.8

 
$
26.3

Total expected net charges
$
21.0

 
$
1.7

 
$
22.7

 
$
1.6

 
$
1.4

 
$
0.8

 
$
26.5


(a) 
Returns are recorded as a reduction to net sales in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss).
(b) 
Inventory write-offs are recorded within cost of sales in the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss).
(c) 
Other charges are recorded within SG&A expenses within the Company’s Consolidated Statements of Operations and Comprehensive Income (Loss).
(d) 
Included within the $18.4 million of employee severance and other personnel benefits is a net pension curtailment gain of $1.5 million recognized in the year ended December 31, 2012.
(e) 
Included within the $(0.8) million of other is a $2.5 million gain on the July 2013 sale of the Company's manufacturing facility in France, which was recognized in the third quarter of 2013.
The Company expects net cash payments to total approximately $24 million related to the September 2012 Program, of which $3.8 million was paid in 2012, $13.3 million was paid during the nine months ended September 30, 2013, approximately $4 million is expected to be paid during the fourth quarter of 2013 and the remainder in expected to be paid in 2014. The total expected net cash payments of $24 million include cash proceeds of $2.7 million received in the third quarter of 2013 related to the sale of the Company's manufacturing facility in France.
Details of the movements in the restructuring reserve during the first nine months of 2013 are as follows:
 
 
 
 
 
 
 
Utilized, Net
 
 
Balance
as of January 1, 2013
 
(Income)
Expense, Net (a)
 
Foreign Currency Translation
 

Cash
 

Noncash
 
Balance as of September 30,
2013
September 2012 Program:
 
 
 
 
 
 
 
 
 
Employee severance and other personnel benefits
$
18.0

 
$
2.6

 
$
(0.2
)
 
$
(13.5
)
 
$

 
$
6.9

Other
0.9

 
1.7

 

 
(2.3
)
 

 
0.3

Lease exit
0.3

 

 

 
(0.3
)
 

 

Total restructuring reserve
$
19.2

 
4.3

 
$
(0.2
)
 
$
(16.1
)
 
$

 
$
7.2

Gain on sale of France facility
 
 
(2.5
)
 
 
 
 
 
 
 
 
Total restructuring charges and other, net
 
 
$
1.8

 
 
 
 
 
 
 
 


(a) During the nine months ended September 30, 2013, the Company recorded additional charges related to the September 2012 Program primarily due to changes in estimates related to severance and other termination benefits, partially offset by a $2.5 million gain on the July 2013 sale of the Company's manufacturing facility in France.
As of September 30, 2013 and December 31, 2012, the restructuring reserve balance was included within accrued expenses and other in the Company's Consolidated Balance Sheets.